BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15107846)

  • 1. Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors.
    Chuang TH; Ulevitch RJ
    Nat Immunol; 2004 May; 5(5):495-502. PubMed ID: 15107846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triad3A regulates ubiquitination and proteasomal degradation of RIP1 following disruption of Hsp90 binding.
    Fearns C; Pan Q; Mathison JC; Chuang TH
    J Biol Chem; 2006 Nov; 281(45):34592-600. PubMed ID: 16968706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triad3A attenuates pathological cardiac hypertrophy involving the augmentation of ubiquitination-mediated degradation of TLR4 and TLR9.
    Lu X; He Y; Tang C; Wang X; Que L; Zhu G; Liu L; Ha T; Chen Q; Li C; Xu Y; Li J; Li Y
    Basic Res Cardiol; 2020 Feb; 115(2):19. PubMed ID: 32008145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation.
    Nakhaei P; Mesplede T; Solis M; Sun Q; Zhao T; Yang L; Chuang TH; Ware CF; Lin R; Hiscott J
    PLoS Pathog; 2009 Nov; 5(11):e1000650. PubMed ID: 19893624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
    Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
    Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors as sensors of pathogens.
    Hallman M; Rämet M; Ezekowitz RA
    Pediatr Res; 2001 Sep; 50(3):315-21. PubMed ID: 11518816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells.
    Schaefer TM; Desouza K; Fahey JV; Beagley KW; Wira CR
    Immunology; 2004 Jul; 112(3):428-36. PubMed ID: 15196211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deviation from major codons in the Toll-like receptor genes is associated with low Toll-like receptor expression.
    Zhong F; Cao W; Chan E; Tay PN; Cahya FF; Zhang H; Lu J
    Immunology; 2005 Jan; 114(1):83-93. PubMed ID: 15606798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triad3A-Mediated K48-Linked ubiquitination and degradation of TLR9 impairs mitochondrial bioenergetics and exacerbates diabetic cardiomyopathy.
    Kong C; Guo Z; Liu F; Tang N; Wang M; Yang D; Li C; Yang Z; Ma Y; Wang P; Tang Q
    J Adv Res; 2024 Jul; 61():65-81. PubMed ID: 37625569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture.
    Uehara A; Yang S; Fujimoto Y; Fukase K; Kusumoto S; Shibata K; Sugawara S; Takada H
    Cell Microbiol; 2005 Jan; 7(1):53-61. PubMed ID: 15617523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Toll-like receptor 4 region Glu24-Pro34 is critical for interaction with MD-2.
    Nishitani C; Mitsuzawa H; Hyakushima N; Sano H; Matsushima N; Kuroki Y
    Biochem Biophys Res Commun; 2005 Mar; 328(2):586-90. PubMed ID: 15694388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T; Barton GM; Flavell RA; Medzhitov R
    Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The E3 ubiquitin ligase RNF182 inhibits TLR-triggered cytokine production through promoting p65 ubiquitination and degradation.
    Cao Y; Sun Y; Chang H; Sun X; Yang S
    FEBS Lett; 2019 Nov; 593(22):3210-3219. PubMed ID: 31432514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection.
    Tabeta K; Georgel P; Janssen E; Du X; Hoebe K; Crozat K; Mudd S; Shamel L; Sovath S; Goode J; Alexopoulou L; Flavell RA; Beutler B
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3516-21. PubMed ID: 14993594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulation of toll-like receptor-mediated signaling by Tollip.
    Zhang G; Ghosh S
    J Biol Chem; 2002 Mar; 277(9):7059-65. PubMed ID: 11751856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cultured astrocytes express toll-like receptors for bacterial products.
    Bowman CC; Rasley A; Tranguch SL; Marriott I
    Glia; 2003 Sep; 43(3):281-91. PubMed ID: 12898707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock up-regulates expression of Toll-like receptor-2 and Toll-like receptor-4 in human monocytes via p38 kinase signal pathway.
    Zhou J; An H; Xu H; Liu S; Cao X
    Immunology; 2005 Apr; 114(4):522-30. PubMed ID: 15804289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A20 inhibits toll-like receptor 2- and 4-mediated interleukin-8 synthesis in airway epithelial cells.
    Gon Y; Asai Y; Hashimoto S; Mizumura K; Jibiki I; Machino T; Ra C; Horie T
    Am J Respir Cell Mol Biol; 2004 Sep; 31(3):330-6. PubMed ID: 15142865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitylation of an internalized killer cell Ig-like receptor by Triad3A disrupts sustained NF-κB signaling.
    Miah SM; Purdy AK; Rodin NB; MacFarlane AW; Oshinsky J; Alvarez-Arias DA; Campbell KS
    J Immunol; 2011 Mar; 186(5):2959-69. PubMed ID: 21270397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Toll-like receptors in healthy and allergic conjunctiva.
    Bonini S; Micera A; Iovieno A; Lambiase A; Bonini S
    Ophthalmology; 2005 Sep; 112(9):1528; discussion 1548-9. PubMed ID: 16023216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.